Doctors and scientists have successfully tested a neoantigen-specific transgenic immune cell therapy for malignant brain tumors for the first time using an experimental model in mice.
source https://www.sciencedaily.com/releases/2021/11/211115123437.htm
Tuesday, 16 November 2021
Related Posts
Molecular underpinnings of a disease affecting corals
Virtual learning may help NICU nurses recognize baby pain
Thyroid cancer now diagnosed with machine learning-powered photoacoustic/ultrasound imaging
Training helps teachers anticipate how students with learning disabilities might solve problems
Sensing 'junk' RNA after chemotherapy enhances blood regeneration
Vocal music boosts the recovery of language functions after stroke
0 comments: